Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominantly inherited disorder of the fibrovascular tissue. The most common symptoms are recurrent nose bleeds and multiple mucocutaneous telangiectases. Arteriovenous malformations (AVMs) are less obvious. Because there is no permanent cure available, patients often suffer from mental stress. Several studies have been performed to assess the quality of life (QoL) of HHT patients. These studies showed that HHT patients rated bodily pain lower than the general population but altogether they had lower health-related QoL.
No takes yet. Share an insight, caveat, or question.
Holderried et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: